Hydrochlorothiazide
- Product NDC
- 50436-3922
- 11-digit product format
- 504363922
- Labeler code
- 50436
- Product ID
- 50436-3922_e3d78a24-d4e9-4790-b2be-82cd74c5bca0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA084325
- Marketing category
- ANDA
- Marketing start
- 2007-05-01
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 50436-3922 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 50436-3922 | 50436-3922-1 | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 50436-3922 | 50436-3922-3 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A084325-001 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | | Approved before 1982 | |